Fluticasone propionate/formoterol fumarate combination therapy is equally effective and well-tolerated when administered with or without a spacer device to patients with asthma - Amsterdam 2011

CDN Connection Issue

It appears that your current network does not allow connection to the CDN (Content Delivery Network) required for this service to function properly.

To resolve this issue, please try the following actions :

• Contact your network administrator : Inform them of this restriction so they can adjust the network settings accordingly.

• Use another network : Try connecting from a different network, such as another Wi-Fi network or a mobile connection.

We apologize for the inconvenience and thank you for your understanding.

International Congresses Amsterdam 2011

Drug delivery and pharmacokinetics II

Chair(s): O. Usmani (London, United Kingdom), M. Molimard (Bordeaux, France), H. Chrystyn (Huddersfield, United Kingdom), J. C. Virchow (Rostock, Germany)

Session type: Thematic Poster Session

Fluticasone propionate/formoterol fumarate combination therapy is equally effective and well-tolerated when administered with or without a spacer device to patients with asthma

D. Price, A. Papi, K. Kaiser, B. Grothe, M. Lomax (Aberdeen, Cambridge, United Kingdom; Ferrara, Italy; Muttenz, Switzerland)

EVENTS HOME

Limited Access

Please log in to myERS to view this content.

Don't have a myERS account? Register

Note: consult the ERS Respiratory Channel access rights page for more details.

CDN Connection Issue

The ERS International Congress 2011, Amsterdam

Limited Access

#{title}